Anti-neoplastic, anti-viral and ribonucleotide reductase activit

Details Anti-neoplastic, anti-viral and ribonucleotide reductase activit Anti-neoplastic, anti-viral and ribonucleotide reductase activit

1994-09-02

1995-11-14

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514375, 514408, 514411, 514422, 514423, A01N 4376, A61K 3142

Patent

active

054667020

ABSTRACT:
A method for treating a human or non-human animal afflicted with malignant cells sensitive to parabactin or vibriobactin or a pharmaceutically acceptable salt or complex thereof comprising administering to the animal an amount of parabactin or vibriobactin effective to inhibit the proliferation of the malignant cells.

REFERENCES:
patent: 5128353 (1992-07-01), Bergeron
Chemical Abstracts 104 (25) 218731b Bergeron et al "Effects of the Vibrio Cholerae Siderophore Vibriobactin on the Growth Characteristics of L1210 Cells" (1986).
Chem Abstracts 101 (11) 83660t (1986).
Chem Abstracts 105 (5) 42565e (1986).

Affiliated with

Also associated with

Rating

Anti-neoplastic, anti-viral and ribonucleotide reductase activit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-neoplastic, anti-viral and ribonucleotide reductase activit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-neoplastic, anti-viral and ribonucleotide reductase activit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1221206